Role of microRNA-regulated cancer stem cells in recurrent hepatocellular carcinoma

被引：7
作者：
Li, Lei [1 ]
Xun, Chen [2 ]
Yu, Chun-Hong [3 ,4 ]
机构：
[1] Univ Otago, Dept Pathol, Dunedin 9016, New Zealand
[2] Zhuzhou Cent Hosp, Dept Hepatobiliary Surg, Zhuzhou 412000, Hunan, Peoples R China
[3] Beihang Univ, Sch Engn Med, Beijing 100191, Peoples R China
[4] Beihang Univ, Sch Engn Med, 37 Xueyuan Rd, Beijing 100191, Peoples R China
来源：
WORLD JOURNAL OF HEPATOLOGY | 2022年 / 14卷 / 12期
关键词：
Hepatocellular carcinoma; Cancer stem cells; MicroRNAs; Recurrence; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; SELF-RENEWAL; SORAFENIB RESISTANCE; THERAPEUTIC TARGET; LIVER; EXPRESSION; METASTASIS; EPCAM; MIGRATION;
D O I：
10.4254/wjh.v14.i12.1985
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Among the most common cancers, hepatocellular carcinoma (HCC) has a high rate of tumor recurrence, tumor dormancy, and drug resistance after initial successful chemotherapy or radiotherapy. A small subset of cancer cells, cancer stem cells (CSCs), exhibit stem cell characteristics and are present in various cancers, including HCC. The dysregulation of microRNAs (miRNAs) often accompanies the occurrence and development of HCC. miRNAs can influence tumorigenesis, progression, recurrence, and drug resistance by regulating CSCs properties, which supports their clinical utility in managing and treating HCC. This review summarizes the regulatory effects of miRNAs on CSCs in HCC with a special focus on their impact on HCC recurrence.
引用
收藏
页码：1985 / 1996
页数：12
相关论文
共 105 条
  • [1] MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG
    Ai, Jiyuan
    Gong, Chengwu
    Wu, Junjun
    Gao, Jun
    Liu, Weiwei
    Liao, Wenjun
    Wu, Linquan
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3455 - 3467
  • [2] Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
    Cao, Liang-qi
    Yang, Xue-wei
    Chen, Yu-bin
    Zhang, Da-wei
    Jiang, Xiao-Feng
    Xue, Ping
    [J]. MOLECULAR CANCER, 2019, 18 (01)
  • [3] miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a
    Cao, Man-Qing
    You, A-Bin
    Zhu, Xiao-Dong
    Zhang, Wei
    Zhang, Yuan-Yuan
    Zhang, Shi-Zhe
    Zhang, Ke-wei
    Cai, Hao
    Shi, Wen-Kai
    Li, Xiao-Long
    Li, Kang-Shuai
    Gao, Dong-Mei
    Ma, De-Ning
    Ye, Bo-Gen
    Wang, Cheng-Hao
    Qin, Cheng-Dong
    Sun, Hui-Chuan
    Zhang, Ti
    Tang, Zhao-You
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [4] Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133
    Chai, Stella
    Tong, Man
    Ng, Kai Yu
    Kwan, Pak Shing
    Chan, Yuen Piu
    Fung, Tsun Ming
    Lee, Terence K.
    Wong, Nathalie
    Xie, Dan
    Yuan, Yun-Fei
    Guan, Xin-Yuan
    Ma, Stephanie
    [J]. ONCOTARGET, 2014, 5 (14) : 5725 - 5735
  • [5] Prognostic significance of miR-203 and ZEB1 expression in early-stage hepatocellular carcinoma
    Chen, Hongyuan
    Kong, Meng
    Chen, Ying
    Jiang, Yugang
    Wen, Mingxin
    Zhang, Xinke
    [J]. JOURNAL OF CANCER, 2021, 12 (16): : 4810 - 4818
  • [6] Macrophages induce CD47 upregulation via IL-6 and correlate with poor survival in hepatocellular carcinoma patients
    Chen, Jing
    Zheng, Dan-Xue
    Yu, Xing-Juan
    Sun, Hong-Wei
    Xu, Yi-Tuo
    Zhang, Yao-Jun
    Xu, Jing
    [J]. ONCOIMMUNOLOGY, 2019, 8 (11):
  • [7] MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
    Chen, Shu-peng
    Liu, Bao-xin
    Xu, Jie
    Pei, Xiao-feng
    Liao, Yi-ji
    Yuan, Feng
    Zheng, Fang
    [J]. BMC CANCER, 2015, 15
  • [8] MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma
    Chen, Shu-ying
    Ma, De-ning
    Chen, Qiu-dan
    Zhang, Jing-jun
    Tian, Yue-ru
    Wang, Zhi-cheng
    Cai, Hao
    Lin, Yong
    Sun, Hui-chuan
    [J]. JOURNAL OF CANCER, 2017, 8 (04): : 617 - 625
  • [9] Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
    Coulouarn, C.
    Factor, V. M.
    Andersen, J. B.
    Durkin, M. E.
    Thorgeirsson, S. S.
    [J]. ONCOGENE, 2009, 28 (40) : 3526 - 3536
  • [10] Induction of tumor initiation is dependent on CD44s in c-Met+ hepatocellular carcinoma
    Dang, Hien
    Steinway, Steven N.
    Ding, Wei
    Rountree, Carl B.
    [J]. BMC CANCER, 2015, 15
12345678910